Drawing for HEMOSEAL

USPTO serial 50184165

HEMOSEAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with HEMOSEAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tom Dao

Tom Dao ALUMEN IP LAW PC15615 Alton ParkwaySuite 450Irvine, CA 92618

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus for use in treating circulatory issues, namely sealing devices and cartridge seals for use in pumps, in percutaneous mechanical circulatory support (pMCS) pumps.ACTIVE—
017Non-metal seals for use in pumps, namely sealing devices and cartridge seals with polymeric seal elements for use in percutaneous mechanical circulatory support (pMCS) pumps.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance